SEATTLE--(BUSINESS WIRE)--Arivale, a company dedicated to providing individuals a scientific path to wellness, announced today it closed a $36 million Series B funding round led by technology and healthcare venture firms ARCH Venture Partners and Polaris Partners, with participation from the consumer-only venture fund Maveron. This funding round followed the Series A round, led by Maveron. Arivale uses cutting-edge science, personalized data and tailored coaching to deliver prioritized, actiona
| < Prev | Next > |
|---|
